.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Argus Health
Julphar
Chinese Patent Office
US Department of Justice
McKinsey
Farmers Insurance
US Army
UBS

Generated: December 13, 2017

DrugPatentWatch Database Preview

Patent Applications for NYMALIZE

« Back to Dashboard

US Patent Applications for NYMALIZE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeOral delivery of discrete units2001-01-19Patented Case2001-12-06
► Subscribe► SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
► Subscribe► SubscribeCONTRAST AGENTS1999-04-14Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-05-19
► Subscribe► SubscribePharmaceutical composition for angiotensin II-mediated diseases2001-01-12Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-03-17
► Subscribe► SubscribeSOLID SOLUTION BEADLET1998-09-18Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-03-14
► Subscribe► SubscribeGENE TRANSCRIPTION AND IONIZING RADIATION: METHODS AND COMPOSITIONS2000-12-05Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-06-09
► Subscribe► SubscribeDIAGNOSING AN ANIMAL FOR PYROPHOSPHATE GOUT, OSTEOPOROSIS , OR OSTEOARTHRITIS BY ASSAYING INTRACELLULAR PYROPHOSPHATE CONTENT IN PERIPHERAL BLOOD CELLS2001-01-04Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622011-03-21
► Subscribe► SubscribePHARMACEUTICAL COMPOSITION FOR ANGIOTENSIN II-MEDIATED DISEASES2001-02-15Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-08-11
► Subscribe► SubscribeCompositions and methods for the treatment of anorectal disorders2001-01-23Abandoned -- Failure to Respond to an Office Action2006-02-21
► Subscribe► SubscribeTryptophanyl-esters and their n-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes2001-03-16Abandoned -- Failure to Respond to an Office Action2004-03-19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
McKesson
Boehringer Ingelheim
US Department of Justice
Fuji
Harvard Business School
Merck
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot